STAAR Surgical | STAA - Umsatzerlöse

Aktienkurs
25.67
Täglich Wechseln
0.83 3.34%
Monatlich
33.77%
Jährlich
42.37%
Q2 Prognose
25.12




Der Umsatz Veränderung Datum
Abbott USD 11.16B 300M 2026-03
Bausch Health Companies USD 2.8B 120M 2025-12
Boston Scientific USD 5.2B 90M 2026-03
Cerus USD 50.81M 4.79M 2024-12
Cooper Companies USD 1.02B 41.1M 2025-12
J&J USD 24.1B 500M 2026-03
Merit Medical Systems USD 393.9M 9.7M 2025-12
Novartis USD 13.86B 50M 2025-12
OraSure Technologies USD 26.76M 322K 2025-12
Orthofix International USD 219.91M 14.28M 2025-12
Rockwell Medical USD 25.83M 3.15M 2024-06
STAAR Surgical USD 239.4M 144.7M 2025-12
Utah Medical Products USD 9.04M 955K 2025-12